BioCentury | Apr 21, 2014
Financial News

Mucosis completes venture financing

...Netherlands Business: Infectious Date completed: 4/15/14 Type: Venture financing Raised: €5 million ($6.9 million) Investors: Changchun BCHT...
BioCentury | Apr 21, 2014
Company News

Changchun BCHT, Mucosis deal

...is comprised of BLP-based Mimopath technology carrying trimeric fusion proteins and is in preclinical testing. Changchun BCHT Biotechnology Co....
BioCentury | Feb 20, 2012
Company News

BioDiem, Changchun BCHT deal

...free-of-charge or at low cost (see BioCentury, July 19, 2010). BioDiem Ltd. (ASX:BDM), Melbourne, Australia Changchun BCHT Biotechnology Co....
Items per page:
1 - 3 of 3
BioCentury | Apr 21, 2014
Financial News

Mucosis completes venture financing

...Netherlands Business: Infectious Date completed: 4/15/14 Type: Venture financing Raised: €5 million ($6.9 million) Investors: Changchun BCHT...
BioCentury | Apr 21, 2014
Company News

Changchun BCHT, Mucosis deal

...is comprised of BLP-based Mimopath technology carrying trimeric fusion proteins and is in preclinical testing. Changchun BCHT Biotechnology Co....
BioCentury | Feb 20, 2012
Company News

BioDiem, Changchun BCHT deal

...free-of-charge or at low cost (see BioCentury, July 19, 2010). BioDiem Ltd. (ASX:BDM), Melbourne, Australia Changchun BCHT Biotechnology Co....
Items per page:
1 - 3 of 3